Kellows Bio is a one-stop chemical multidimensional omics R&D and service platform, focusing on protein target discovery and covalent drug lead compound screening. The company takes cutting-edge chemical proteomics technology as the core, and its main business covers protein chemical labeling technology services and related chemical probe research and development and production. Recently, it has completed tens of millions of yuan in pre-A round of financing, which is used for the improvement of the company’s hardware platform and team capacity building, and to accelerate the establishment of the innovative drug lead compound screening platform. This round of financing was led by Huatai Trust Fund, a subsidiary of Huatai Zijin, and Shuimu Pilot Fund, a subsidiary of Beijing Tsinghua Industrial Development Research Institute, and Nanjing Jiangbei Science and Technology Investment Group as co-investors.
This article is reproduced from: https://www.itjuzi.com/investevent/13273573
This site is for inclusion only, and the copyright belongs to the original author.